Aadi Bioscience, Inc. (AADI) Financials

AADI Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2024 70.3 million 17.8 million
Sept. 30, 2024 85.7 million 16.8 million
June 30, 2024 101.6 million 22.8 million
March 31, 2024 111.1 million 20.6 million

AADI Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2024 ? ?
Sept. 30, 2024 -20.5 million 9.1 million
June 30, 2024 -9.7 million 2.8 million
March 31, 2024 -20.4 million 3.6 million

AADI Net Income

No data available :(

AADI Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2024 47.2 million 565000 833000
Sept. 30, 2024 62.6 million 624000 946000
June 30, 2024 78.6 million 682000 1.1 million
March 31, 2024 88.3 million 738000 1.2 million

AADI Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2024 ?
Sept. 30, 2024 24.7 million
June 30, 2024 27.0 million
March 31, 2024 27.0 million

AADI Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2024 - 14.3 million 11.1 million -
Sept. 30, 2024 2.3 million 10.0 million 7.2 million -
June 30, 2024 541000 13.1 million 7.9 million -
March 31, 2024 739000 13.6 million 10.6 million -

AADI Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2024 7.2 million 790000
Sept. 30, 2024 7.2 million 804000
June 30, 2024 6.2 million 778000
March 31, 2024 5.4 million 652000

AADI Revenue by Segment

Graph available only for paid members. Upgrade to see it.

AADI

Price: $2.05

52 week price:
1.21
3.81

Earnings Per Share: -2.36 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 52100

Market Capitalization: 94.9 million

Links: